Exploration of the molecular mechanism of prostate cancer based on mRNA and miRNA expression profiles

References

• SiegelRLMillerKDJemalACancer statistics, 2015CA Cancer J Clin201565152925559415
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research NetworkThe molecular taxonomy of primary prostate cancerCell201516341011102526544944
   PubMed Web of Science ®Google Scholar
• ChenRRenSYiuMKProstate cancer in Asia: a collaborative reportAsian J Urol2014111529
   PubMedGoogle Scholar
• EdwardsBKNooneAMMariottoABAnnual Report to the Nation on the status of cancer, 1975–2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancerCancer201412091290131424343171
   PubMed Web of Science ®Google Scholar
• Al OlamaAAKote-JaraiZBerndtSIA meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancerNat Genet201446101103110925217961
   PubMed Web of Science ®Google Scholar
• HaeseAde la TailleAvan PoppelHClinical utility of the PCA3 urine assay in European men scheduled for repeat biopsyEur Urol20085451081108818602209
   PubMed Web of Science ®Google Scholar
• GuazzoniGNavaLLazzeriMProstate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical settingEur Urol201160221422221482022
   PubMed Web of Science ®Google Scholar
• TomlinsSARhodesDRPernerSRecurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancerScience2005310574864464816254181
   PubMed Web of Science ®Google Scholar
• RenSWangFShenJLong non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancerEur J Cancer201349132949295923726266
   PubMed Web of Science ®Google Scholar
• BarbieriCEBacaSCLawrenceMSExome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancerNat Genet201244668568922610119
   PubMed Web of Science ®Google Scholar
• MageeJAArakiTPatilSExpression profiling reveals hepsin overexpression in prostate cancerCancer Res200161155692569611479199
   PubMedGoogle Scholar
• DhanasekaranSMBarretteTRGhoshDDelineation of prognostic biomarkers in prostate cancerNature2001412684982282611518967
   PubMed Web of Science ®Google Scholar
• LaTulippeESatagopanJSmithAComprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic diseaseCancer Res200262154499450612154061
   PubMed Web of Science ®Google Scholar
• MortensenMMHoyerSLynnerupASExpression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomySci Rep201551601826522007
   PubMed Web of Science ®Google Scholar
• ArredouaniMSLuBBhasinMIdentification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancerClin Cancer Res200915185794580219737960
   PubMed Web of Science ®Google Scholar
• GentlemanRCCareyVJBatesDMBioconductor: open software development for computational biology and bioinformaticsGenome Biol2004510R8015461798
   PubMed Web of Science ®Google Scholar
• KerrMKLinear models for microarray data analysis: hidden similarities and differencesJ Comput Biol200310689190114980016
   PubMedGoogle Scholar
• HadleyWGgplot2: Elegant Graphics for Data AnalysisSwitzerlandSpringer2016
   Google Scholar
• DennisGJrShermanBTHosackDADAVID: database for annotation, visualization, and integrated discoveryGenome Biol2003453
   PubMed Web of Science ®Google Scholar
• AcunzoMCroceCMMicroRNA in cancer and cachexia – a mini-reviewJ Infect Dis2015212suppl 1S74S7726116737
   PubMed Web of Science ®Google Scholar
• AlhasanAHScottAWWuJJCirculating microRNA signature for the diagnosis of very high-risk prostate cancerProc Natl Acad Sci U S A201611338106551066027601638
   PubMed Web of Science ®Google Scholar
• ShannonPMarkielAOzierOCytoscape: a software environment for integrated models of biomolecular interaction networksGenome Res200313112498250414597658
   PubMed Web of Science ®Google Scholar
• Aguirre-GamboaRGomez-RuedaHMartinez-LedesmaESurvExpress: an online biomarker validation tool and database for cancer gene expression data using survival analysisPLoS One201389e7425024066126
   PubMed Web of Science ®Google Scholar
• SbonerADemichelisFCalzaSMolecular sampling of prostate cancer: a dilemma for predicting disease progressionBMC Med Genomics20103820233430
   PubMedGoogle Scholar
• GulzarZGMcKenneyJKBrooksJDIncreased expression of NuSAP in recurrent prostate cancer is mediated by E2F1Oncogene2013321707722349817
   PubMed Web of Science ®Google Scholar
• YouJWangLHuangJLow glucose transporter SLC2A5-inhibited human normal adjacent lung adenocarcinoma cytoplasmic pro-B cell development mechanism networkMol Cell Biochem20153991–2717625326153
   PubMedGoogle Scholar
• PinggeraALiebABenedettiBCACNA1D de novo mutations in autism spectrum disorders activate Cav1.3 L-type calcium channelsBiol Psychiatry201577981682225620733
   PubMed Web of Science ®Google Scholar
• GanapathyVThangarajuMPrasadPDNutrient transporters in cancer: relevance to Warburg hypothesis and beyondPharmacol Ther20091211294018992769
   PubMed Web of Science ®Google Scholar
• MoscatJRichardsonADiaz-MecoMTNutrient stress revamps cancer cell metabolismCell Res201525553753825828529
   PubMedGoogle Scholar
• FukusumiYWakamatsuATakashimaNSV2B is essential for the integrity of the glomerular filtration barrierLab Invest201595553454525730372
   PubMedGoogle Scholar
• CleggNFergusonCTrueLDMolecular characterization of prostatic small-cell neuroendocrine carcinomaProstate2003551556412640661
   PubMedGoogle Scholar
• IezziMTheanderSJanzRLozeCWollheimCBSV2A and SV2C are not vesicular Ca2+ transporters but control glucose-evoked granule recruitmentJ Cell Sci2005118pt 235647566016306227
   PubMedGoogle Scholar
• SamuelSNaoraHHomeobox gene expression in cancer: insights from developmental regulation and deregulationEur J Cancer200541162428243716199152
   PubMed Web of Science ®Google Scholar
• JungCKimRSLeeSJWangCJengMHHOXB13 homeodomain protein suppresses the growth of prostate cancer cells by the negative regulation of T-cell factor 4Cancer Res20046493046305115126340
   PubMed Web of Science ®Google Scholar
• JungCKimRSZhangHHOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivationBr J Cancer200592122233223915928669
   PubMed Web of Science ®Google Scholar
• ShapovalovGSkrymaRPrevarskayaNCalcium channels and prostate cancerRecent Pat Anticancer Drug Discov201381182622694290
   PubMed Web of Science ®Google Scholar
• GrahamSMHolzbeierleinJMThrasherJBLiBCalcium channel blocker modulates androgen receptor-mediated gene expression and induces cytotoxicity in prostate cancer cellsJ Urol20121874e94
   Google Scholar